Furthermore, the validated genes and some signaling pathways rarely reported in researches on sarcopenia, for example, VEGF, cGMP-PKG and HIF-1 signaling pathway, are potential to be therapeutic targets. This evidence concerns the gene VEGFA and sarcopenia.